Anti-Rolitetracycline (Pyrrolidinylmethyltetracycline, SQ 15659)
(4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-(1-pyrrolidinylmethyl)-2-naphthacenecarboxamide; 4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-(1-pyrrolidinylmethyl)-2-naphthacenecarboxamide; Abricycline; Bristacin; N-(1-Pyrrolidinylmethyl)tetracycline; N-(Pyrrolidinomethyl)tetracycline; Pyrrolidinylmethyltetracycline; Reverin; Rolitetracycline; SQ 15659; Superciclin; Synotodecin; Syntetrin; Tetraverin; Transcycline; Velacycline
Rolitetracycline is a tetracycline antibiotic that may be given intravenously or intramuscularly in serious bacterial infections when oral administration is not practicable.
Synonyms
(4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-(1-pyrrolidinylmethyl)-2-naphthacenecarboxamide; 4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-(1-pyrrolidinylmethyl)-2-naphthacenecarboxamide; Abricycline; Bristacin; N-(1-Pyrrolidinylmethyl)tetracycline; N-(Pyrrolidinomethyl)tetracycline; Pyrrolidinylmethyltetracycline; Reverin; Rolitetracycline; SQ 15659; Superciclin; Synotodecin; Syntetrin; Tetraverin; Transcycline; Velacycline
Molecular Formula
C₂₇H₃₃N₃O₈
Appearance
Very dark red to very dark brown solid
Solubility
DMSO (Slightly), Methanol (Very Slightly)
Method For Determining Identity
Proton NMR (DMSO-d6) Spectroscopic and Mass Spectrometric analysis
TLC Conditions
C18; Water: Acetonitrile: Acetic Acid=8:2:02; Visualized with UV and AMCS; Single Spot, f=0.30
Storage and Stability
May be stored at RT for short-term only. Long-term storage is recommended at -20°C. Stable for 6 months after receipt. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Hygroscopic. Store under inert atmosphere.
Important Note
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
Toxicity and Hazards
All products should be handled by qualified personnel only, trained in laboratory procedures.
Form
Very dark red to very dark brown solid
